Intraarterial catheter-directed thrombolysis: Urokinase versus tissue plasminogen activator

Annals of Vascular Surgery

Volumn 13, Issue 6, 1999, Pages 571-575

  Cinà, Claudio S ^a,b   Goh, Raymond H ^a   Chan, Jean ^a   Kenny, Brian ^a   Evans, Geoffrey ^a   Rawlinson, John ^a   Gill, Gerald ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Victoria Medical Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; AGED; BLOOD CLOT LYSIS; CONFERENCE PAPER; CONTINUOUS INFUSION; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; GASTROINTESTINAL HEMORRHAGE; HEMATOMA; HUMAN; HUMAN TISSUE; INCIDENCE; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; RETROPERITONEAL HEMORRHAGE; SURGICAL TECHNIQUE; THROMBOSIS; TREATMENT OUTCOME;

EID: 0032692376     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100169900300     Document Type: Conference Paper

References (19)

1. Ouriel K, Veith FJ, Sasahara AA, Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs [see comments]. N Engl J Med 1998;338:1105-1111.
2. Ouriel K, Veith FJ, Sasahara AA, TOPAS Investigators. Thrombolysis or peripheral arterial surgery: phase I results [see comments]. J Vasc Surg 1996;23:64-73.
3. Comerota AJ, Cohen GS. Thrombolitic therapy in peripheral arterial occlusive disease: mechanism of action and drugs available. Can J Surg 1993;36:342-347.
4. Verstraete M. Thrombolysis for arterial conditions other than myocardial infarction [review]. Coron Artery Dis 1994; 5:317-321.
5. Verstraete M, Broy M, Collen D, et al. Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction: report from the European Cooperative Study Group for Recombinant Tissue Type Plasminogen Activator. Lancet 1985;1:842-847.
6. Vignali C, Cioni R, Mascalchi M, et al. Urochinasi e attivatore tissutale del plasminogeno a confronto nella fibrinolisi arteriosa transcatetere. Radiol Med 1994;88:93-99.
7. The Stile Investigators. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Vasc Surg 1994; 220:251-268.
8. Comerota AJ, Weaver FA. Hosking JD, et al. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts. Am J Surg 1996; 172:105-112.
9. Risius B, Graor RA, Geisinger MA, Zelch MG, Lucas FV, Young JR. Thormbolytic therapy with recombinant tissue-type plaminogen activator: a comparison of two doses. Radiology 1987;164:465-468.
10. Meyerovitz MF, Goldhaber SZ, Reagan K, et al. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial [see comments]. Radiology 1990;175:75-78.
11. Ouriel K, Shortell CK, Azodo MV, Guiterrez OH, Marder VJ. Acute peripheral arterial occlusion: predictors of success in catheter-directed thrombolytic therapy. Radiology 1994; 193:561-566.
12. Rao AK, Pratt C, Berke A, et al. Thrombolysis in myocardial infarction (TIMI) trial phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Cardiol 1988;11:11.
13. Eisenberg PR, Sherman LA, Tiefenbrunn AJ, Ludbrook PA, Sobel BE, Jaffe AS. Sustained fibrinolysis after administration of t-PA despite its short half life in the circulation. Thromb Haemost 1987;57(35):40.
14. Ward AS, Andaz SK, Bygrave S. Thrombolysis with tissueplasminogen activator: results with a high-dose transthrombus technique [see comments]. J Vasc Surg 1994;19:503-508.
15. Ouriel K, Welch EL, Shortell CK, Gearry K, Fiore WM, Cimino C. Comparison of streptokinase, urokinase, and recombinant tissue plasminogen activator in an in vitro model of venous thrombolysis. J Vase Surg 1995;22:593-597.
16. Berridge DC, al-Kutoubi A, Mansfield AO, Nicolaides AN, Wolfe JH. Thrombolysis in arterial graft thrombosis. Eur J Vasc Endovasc Surg 1995;9:129-132.
17. Berridge DC, Gregson RH, Hopkinson BR, Makin GS. Randomized trial of intra-arterial recombinant tissue plasminogen activator, intravenous recombinant tissue plasminogen activator and intra-arterial streptokinase in peripheral arterial thrombolysis. Br J Surg 1991;78:988-995.
18. Braithwaite BD, Birch PA, Poskitt KR, Heather BP, Earnshaw JJ. Accelerated thrombolysis with high dose bolus t-PA extends the role of peripheral thrombolysis but may increase the risks. Clin Radiol 1995;50:747-750.
19. Braithwaite BD, Buckenham TM, Galland RB, Heather BP, Earnshaw JJ, Thrombolysis Study Group. Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischemia. Br J Surg 1997;84:646-650.